Daré Bioscience, Inc. (DARE)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Daré Bioscience, Inc. (DARE)
Go deeper and ask any question about DARE
Company Performance
Current Price
as of Sep 13, 2024$3.31
P/E Ratio
N/A
Market Cap
$28.29M
Description
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.
Metrics
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerDARE
- Price$3.31-1.19%
Trading Information
- Market Cap$28.29M
- Float98.38%
- Average Daily Volume (1m)31,745
- Average Daily Volume (3m)141,721
- EPS-$0.97
Company
- Revenue$2.84M
- Rev Growth (1yr)N/A
- Net Income$12.91M
- Gross Margin31.20%
- EBITDA Margin-32,618.91%
- EBITDA-$7.32M
- EV$23.60M
- EV/Revenue8.31
- P/EN/A
- P/S9.88
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset